Novo Nordisk A/S & Anor v British Telecommunications & Ors

Novo Nordisk A/S & Anor v British Telecommunications & Ors

The Court has jurisdiction to grant a website blocking injunction against ISPs where their services are used to facilitate the advertising and sale of counterfeit and unlicensed prescription-only medicines in breach of the Human Medicines Regulations 2012, and where the Applicants have standing as the rights holders and with the support of the regulator. The order is proportionate, necessary, and includes appropriate safeguards.

Parties
Applicant: Novo Nordisk A/S; Applicant: Novo Nordisk Limited; Respondent: British Telecommunications PLC; Respondent: EE Limited; Respondent: Plusnet PLC; Respondent: Sky UK Limited; Respondent: TalkTalk Telecom Limited; Respondent: Virgin Media Limited
Jurisdiction
England and Wales
Judgment Date
13 May 2026
Procedural Posture
Application for Website Blocking Injunction / Judgment After Hearing of Application
Outcome
Application granted
Legal Topics
Website Blocking Injunctions, Trade Mark Infringement, Passing Off, Breach of Human Medicines Regulations, ISP Liability, Equitable Remedies

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 4 Authorities cited 19 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Parties

Novo Nordisk A/S

Applicant

Novo Nordisk Limited

Applicant

British Telecommunications PLC

Respondent

EE Limited

Respondent

Plusnet PLC

Respondent

Sky UK Limited

Respondent

TalkTalk Telecom Limited

Respondent

Virgin Media Limited

Respondent

Procedural Posture

Application for Website Blocking Injunction / Judgment After Hearing of Application

  1. 1 Whether the Court has jurisdiction to grant a website blocking injunction against ISPs in respect of websites selling counterfeit and unlicensed prescription-only medicines
  2. 2 Whether the Applicants have standing to seek such an injunction based on breaches of the Human Medicines Regulations 2012
  3. 3 Whether the wrongdoing under the Regulations suffices for injunctive relief

Ratio Decidendi

The Court has jurisdiction to grant a website blocking injunction against ISPs where their services are used to facilitate the advertising and sale of counterfeit and unlicensed prescription-only medicines in breach of the Human Medicines Regulations 2012, and where the Applicants have standing as the rights holders and with the support of the regulator. The order is proportionate, necessary, and includes appropriate safeguards.

Court Disposition

Application granted

Orders

  • Website blocking injunction granted against the Respondent ISPs in the terms of the draft order submitted, targeting the specified websites and any mirror or successor sites.
  • Order to include safeguards such as notification provisions, liberty to apply, and a sunset clause of 2 years.